Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Recruiting 3Terminated 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gynecologic 1CNS 1

Conditions

Lung Neoplasms 6Breast Neoplasms 6Uterine Cervical Neoplasms 4Neoplasms 3Neoplasm Metastasis 3Carcinoma, Non-Small-Cell Lung 3Small Cell Lung Carcinoma 2Lymphoma, B-Cell, Marginal Zone 2Liver Neoplasms 2Carcinoma, Ovarian Epithelial 2Carcinoma, Hepatocellular 2Brain Neoplasms 2Unspecified Adult Solid Tumor, Protocol Specific 1Thyroid Neoplasms 1Thyroid Carcinoma, Anaplastic 1Thyroid Cancer, Papillary 1Squamous Cell Carcinoma of Head and Neck 1Sarcoma 1Salivary Gland Neoplasms 1Rectal Neoplasms 1Prostatic Neoplasms 1Precancerous Conditions 1Pleural Effusion, Malignant 1Ovarian Neoplasms 1Neurofibromatosis 1 1Neurofibroma, Plexiform 1Mycosis Fungoides 1Meningioma 1Melanoma 1Lymphoma, T-Cell, Cutaneous 1

Interventions

Carboplatin 44Paclitaxel 43liposomal doxorubicin 23Topotecan 19Gemcitabine 18pembrolizumab 17Cyclophosphamide 17Bevacizumab 16Cisplatin 12niraparib 9olaparib 8fludarabine 7Taxes 7Docetaxel 7aldesleukin 6Nivolumab 6Doxorubicin 61-dodecylpyridoxal 6oregovomab 5fludarabine phosphate 5Peripheral Blood Stem Cell Transplantation 5Filgrastim 5rucaparib 4durvalumab 4avelumab 4Surgical Procedures, Operative 4Melphalan 4Ipilimumab 4Interleukin-2 4Etoposide 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Ovarian Neoplasms × Fluorodeoxyglucose F18 × Clear all
NCT00253461 2012-03-20

11C Topotecan PET Imaging

Case Comprehensive Cancer Center

Phase EARLY_PHASE1 Terminated
7 enrolled
CNSGynecologicThoracic

Carcinoma, Ovarian Epithelial, Brain Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡